Bifidobacterium bifidum G9-1 and Improved Gastrointestinal Symptom Rating Scale Score

• Effects of probiotic Bifidobacterium bifidum G9‐1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open‐label, single‐arm, exploratory research trial

  • 2021-11-15
  • Journal of Diabetes Investigation 13(3)
  • • Shinnosuke Hata
    • Hanako Nakajima
    • Y. Hashimoto
    • Tomoki Miyoshi
    • Yukako Hosomi
    • Takuro Okamura
    • Saori Majima
    • Naoko Nakanishi
    • Takafumi Sennmaru
    • T. Osaka
    • Hiroshi Okada
    • Emi Ushigome
    • M. Hamaguchi
    • M. Asano
    • M. Yamazaki
    • M. Fukui

  • PubMed: 34665938
  • DOI: 10.1111/jdi.13698

  6 Insights on

  • Improved Gastrointestinal Symptom Rating Scale Score

  • Low evidence
  • Rigorous Journal

  The gastrointestinal symptom rating scale total score significantly improved (from 2.02 ± 0.51 to 1.59 ± 0.43, change, -0.43 ± 0.49, P < 0.001).

  Effect

  Beneficial

  Effect size

  Small

  Significant

  Yes